ATHA

Athira Pharma, Inc. - Common Stock (ATHA)

About Athira Pharma, Inc. - Common Stock (ATHA)

Athira Pharma, Inc. engages in the development of small molecules to restore neuronal health and stop neurodegeneration. Its product pipeline includes ATH-1017, ATH-1019/20, and ATH-1018. The company was founded by Leen Kawas, John Wright, Lewis Rumpler, and Joseph Harding in March 2011 and is headquartered in Bothell, WA.

Details

Daily high

$0.33

Daily low

$0.31

Price at open

$0.32

52 Week High

$3.67

52 Week Low

$0.22

Market cap

12.1M

Dividend yield

0.00%

Volume

128,646

Avg. volume

1.4M

P/E ratio

-.15

Athira Pharma, Inc. - Common Stock News